Infantile spasms as an epileptic feature of DEND syndrome associated with an activating mutation in the potassium adenosine triphosphate (ATP) channel, Kir6.2

被引:27
作者
Bahi-Buisson, Nadia
Eisermann, Monica
Nivot, Sylvie
Bellanne-Chantelot, Christine
Dulac, Olivier
Bach, Nathalie
Plouin, Perrine
Chiron, Catherine
de Lonlay, Pascale
机构
[1] Hop Necker Enfants Malad, Dept Pediat Neurol & Metab Dis, Paris, France
[2] INSERM, Paris, France
[3] Univ Paris 05, Paris, France
[4] Hop Necker Enfants Malad, Neurophysiol Unit, Paris, France
[5] Hop Caen, Dept Pediat, Caen, France
[6] Hop St Antoine, Dept Mol Biol, F-75571 Paris, France
关键词
infantile spasms; neonatal diabetes; ATP-sensitive potassium channel; INSIGHTS; THERAPY; SUBUNIT; PORE;
D O I
10.1177/0883073807306272
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Activating mutations in the Kir6.2 subunit of the adenosine triphosphate-sensitive potassium (KATP) channel is a cause of neonatal diabetes associated with various neurological disorders that include (d) under bar evelopmental delay, (e) under bar pilepsy, and (n) under bar eonatal (d) under bar iabetes (known together as DEND syndrome). This article reports a girl who developed infantile spasms and early onset diabetes mellitus at the age of 3 months and revealed DEND syndrome with a heterozygous activating mutation in Kir6.2. Infantile spasms with hypsarrhythmia on the electroencephalogram were severe and refractory to steroids. Steroids combined with oral sulfonylurea, a drug that closes the ATP-sensitive potassium channel by an independent mechanism, allowed partial and transitory control of the epilepsy. However, the child still exhibited severe encephalopathy and died of aspiration pneumonia. The role of oral sulfonylurea as an anticonvulsant in DEND syndrome associated with Kir6.2 mutation is discussed.
引用
收藏
页码:1147 / 1150
页数:4
相关论文
共 18 条
[1]   Epileptic encephalopathy [J].
Dulac, O .
EPILEPSIA, 2001, 42 :23-26
[2]   Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes [J].
Gloyn, AL ;
Pearson, ER ;
Antcliff, JF ;
Proks, P ;
Bruining, GJ ;
Slingerland, AS ;
Howard, N ;
Srinivasan, S ;
Silva, JMCL ;
Molnes, J ;
Edghill, EL ;
Frayling, TM ;
Temple, IK ;
Mackay, D ;
Shield, JPH ;
Sumnik, Z ;
van Rhijn, A ;
Wales, JKH ;
Clark, P ;
Gorman, S ;
Aisenberg, J ;
Ellard, S ;
Njolstad, PR ;
Ashcroft, FM ;
Hattersley, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1838-1849
[3]  
Gribble FM, 2002, BIOCHEM SOC T, V30, P333, DOI 10.1042/bst0300333
[4]   Genetics of the epilepsies [J].
Gutierrez-Delicado, E ;
Serratosa, JM .
CURRENT OPINION IN NEUROLOGY, 2004, 17 (02) :147-153
[5]   Activating mutations in Kir6.2 and neonatal diabetes - New clinical syndromes, new scientific insights, and new therapy [J].
Hattersley, AT ;
Ashcroft, FM .
DIABETES, 2005, 54 (09) :2503-2513
[6]   Protection against hypoxic-ischemic injury in transgenic mice overexpressing Kir6.2 channel pore in forebrain [J].
Héron-Milhavet, L ;
Xue-jun, Y ;
Vannucci, SJ ;
Wood, TL ;
Willing, LB ;
Stannard, B ;
Hernandez-Sanchez, C ;
Mobbs, C ;
Virsolvy, A ;
LeRoith, D .
MOLECULAR AND CELLULAR NEUROSCIENCE, 2004, 25 (04) :585-593
[7]   Neuronal KCNQ potassium channels: Physiology and role in disease [J].
Jentsch, TJ .
NATURE REVIEWS NEUROSCIENCE, 2000, 1 (01) :21-30
[8]  
Koyabu Noriko, 2004, Drug Metab Pharmacokinet, V19, P270, DOI 10.2133/dmpk.19.270
[9]   A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome [J].
Proks, P ;
Girard, C ;
Haider, S ;
Gloyn, AL ;
Hattersley, AT ;
Sansom, MSP ;
Ashcroft, FM .
EMBO REPORTS, 2005, 6 (05) :470-475
[10]   Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features [J].
Proks, P ;
Antcliff, JF ;
Lippiat, J ;
Gloyn, AL ;
Hattersley, AT ;
Ashcroft, FM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (50) :17539-17544